MTHFR and Fertility: What Your Result Actually Means
You got your results. MTHFR came back positive.
Maybe your doctor told you it was common and not to worry about it. Maybe you were handed a methylfolate supplement and sent on your way. Maybe you started taking it and felt worse: anxious, wired, emotionally off, and nobody could explain why. Maybe you have been carrying losses or failed cycles or years of trying and this result felt like it might finally be a clue, and then the door closed again before it fully opened.
You are not doing anything wrong. And you are not being dramatic.
What you are is under-investigated. And that is a clinical problem, not a personal one.
MTHFR is one of the most commonly tested and most poorly explained results in the fertility space. Some practitioners treat it as the answer to everything. Many doctors dismiss it as meaningless. The truth is more useful than either of those positions, and it is what I want to give you here.
What MTHFR Actually Is
MTHFR stands for methylenetetrahydrofolate reductase. It is an enzyme your body uses to convert folate into its active, usable form. Think of it like a key-cutting machine. Your body takes in dietary folate, and this enzyme cuts it into the shape that actually opens the doors inside your cells.
When you carry a variant in this gene, that conversion may be less efficient. The two main variants are C677T and A1298C, and they are genuinely common. Many people carry at least one copy. Being positive does not mean you will have fertility problems. It means one part of your biochemistry may be working less efficiently, and whether that matters clinically depends on everything else happening in your body.
The reason it matters at all comes down to what folate actually does. And most people have been told far too little about that.
Folate is not just a pregnancy vitamin. It sits at the centre of methylation, one of the most fundamental biochemical cycles in your body. Methylation is how your DNA is built, repaired, and read. How your genes are switched on and off. How a fertilised egg begins dividing in its very first days. When that cycle is under pressure, the effects are not abstract. They show up in real outcomes.
How This Connects to Fertility
I want to be honest with you about what the research does and does not show, because this is where the most confusion lives.
MTHFR does not directly cause infertility or miscarriage on its own. The evidence on this has evolved significantly over the past decade. Older and smaller studies suggested stronger links between MTHFR variants and recurrent pregnancy loss. More recent and larger analyses have complicated that picture, finding that common MTHFR variants may confer, at most, a modest increase in risk for recurrent pregnancy loss in some populations, and that most early losses are driven by chromosomal issues rather than single gene variants.
So why does it still matter clinically? Because it is rarely sitting alone in the picture.
Homocysteine Is the Piece Most People Are Never Told to Check
When MTHFR function is reduced, homocysteine can accumulate. Homocysteine is an amino acid that, when elevated, is associated with increased inflammation and impaired vascular function. In early pregnancy, the embryo is entirely dependent on your circulation for everything it needs. Elevated homocysteine is associated with impaired vascular function, which can reduce blood flow at exactly the moment it matters most in early pregnancy.
Research has linked elevated homocysteine to disrupted implantation and, in some populations, higher rates of pregnancy complications. And here is the thing: homocysteine is measurable. It is a simple blood test. Most people with a positive MTHFR result are never told to check it.
A gene result tells you about potential. A homocysteine level tells you about function. They are not the same thing.
This is one of the most correctable gaps in how MTHFR is managed clinically. Knowing one without the other is half a picture.
Folate and the Earliest Days of Embryo Development
Folate is required to build DNA, and every cell division requires it. In early embryogenesis, cells are dividing at an extraordinary rate. Research in IVF populations has found that better folate status, including higher follicular fluid folate, is associated with higher pregnancy rates, and this seems to matter for women regardless of whether they carry common MTHFR variants. Functional folate status matters for everyone, and optimising it is one of the most evidence-supported things you can do preconception.
For women (and men) with reduced MTHFR function, the ability to convert dietary and supplemental folate into its active form is the central issue. Which brings us to why the form of folate you are taking matters so much more than most people are told.
MTHFR, IVF, and What Protocol You Are On
The 677TT homozygous variant has been associated with poorer outcomes in specific IVF protocols. One study found that women with this genotype had fewer good-quality embryos and lower cumulative live birth rates under a GnRH agonist short protocol, but not under a long protocol. Context changes the clinical picture significantly. This is not a catastrophic finding. It is a variable worth knowing about and planning around.
What About Him
This is the part of the MTHFR conversation that almost nobody is having, and it should be.
MTHFR variants in men have been associated with changes in sperm parameters including sperm count and DNA integrity. In at least one randomised trial, folic acid supplementation improved semen parameters and reduced sperm DNA fragmentation in men with the 677TT genotype. Fertility is a whole-couple investigation. MTHFR in that picture belongs to both of you, not just the person carrying pregnancies.
If you are reading this and thinking that nobody has ever investigated your partner's MTHFR status or sperm DNA fragmentation, that is worth paying attention to.
Why Methylfolate Made You Feel Worse
This is one of the most common things I hear in clinic. And one of the least well explained by the people who ordered the test.
You have MTHFR. You cannot process folate well. Here is some methylfolate. And then you felt anxious, wired, emotionally raw, or just deeply off in a way you could not quite name.
That reaction is information, not failure.
MTHFR does not operate alone. It sits inside a methylation network that includes many other genes. The most relevant one here is COMT, which affects how your body breaks down oestrogen, dopamine, and adrenaline. If you carry a slower COMT variant alongside your MTHFR variant, adding high-dose methylfolate may push dopamine and adrenaline higher than your nervous system can comfortably manage, which can show up as feeling wired, anxious, or emotionally raw.
The methylation pathway is not a single road. It is a network. Pushing hard on one road without knowing what the rest of the network looks like is exactly where things go wrong.
This is also why the form of folate matters. Standard folic acid, the synthetic form in most generic supplements, requires the MTHFR enzyme to convert it into something usable. For someone with reduced MTHFR function, that conversion is already compromised, and unmetabolised folic acid can accumulate.
The forms I most commonly work with in a fertility context are 5-MTHF, the active methylated form that bypasses the MTHFR step entirely, and folinic acid, which enters the folate cycle at a different point and is often better tolerated by people who are sensitive to methylfolate. Large head-to-head trials comparing these forms in a fertility context are limited, so these choices are made based on biochemistry and individual clinical response rather than definitive outcome trials. The right form, dose, and combination of cofactors depends entirely on your individual picture.
MTHFR Is One Gene in a Larger Conversation
This is the part that most test reports do not tell you, and it may be the most important thing in this entire article.
Your MTHFR result does not tell you how your methylation pathway is actually functioning. It tells you one variable in a complex equation. The same C677T result can look completely different in two different people depending on everything else happening in their biochemistry.
When I look at a genetics panel in a fertility context, I am looking at how multiple genes are talking to each other. Here is a plain-language version of the main ones:
THE BROADER METHYLATION PICTURE
COMT affects how your body processes oestrogen and neurotransmitters. Relevant for oestrogen dominance, mood, and stress response, all of which intersect with fertility.
CBS sits downstream in the methylation pathway and affects how sulphur compounds are processed. Can contribute to oxidative stress if variants are present.
MTRR AND MTR are involved in how B12 is recycled and used. These can compound MTHFR findings and drive homocysteine higher even when MTHFR variants are mild.
TCN2 affects how efficiently B12 gets into your cells. You can have optimal dietary B12 intake and still be functionally deficient if this gene is variant.
VDR affects how your body uses vitamin D. Vitamin D plays a significant role in immune regulation and implantation, and a variant here can mean supplementation does less than expected.
Not every variant in these genes has been clearly linked with fertility outcomes in large studies, but they can meaningfully change how your methylation pathway behaves and how you respond to nutrients. Each one changes what support is appropriate for you specifically.
If you have had MTHFR identified but nobody has looked at the broader pathway, or checked your homocysteine, or asked about how methylfolate is actually making you feel, that gap is worth addressing.
What a Proper Investigation Looks Like
This is the part that most test reports do not tell you, and it may be the most important thing in this entire article.
Your MTHFR result does not tell you how your methylation pathway is actually functioning. It tells you one variable in a complex equation. The same C677T result can look completely different in two different people depending on everything else happening in their biochemistry.
When I look at a genetics panel in a fertility context, I am looking at how multiple genes are talking to each other. Here is a plain-language version of the main ones:
THE BROADER METHYLATION PICTURE
COMT affects how your body processes oestrogen and neurotransmitters. Relevant for oestrogen dominance, mood, and stress response, all of which intersect with fertility.
CBS sits downstream in the methylation pathway and affects how sulphur compounds are processed. Can contribute to oxidative stress if variants are present.
MTRR AND MTR are involved in how B12 is recycled and used. These can compound MTHFR findings and drive homocysteine higher even when MTHFR variants are mild.
TCN2 affects how efficiently B12 gets into your cells. You can have optimal dietary B12 intake and still be functionally deficient if this gene is variant.
VDR affects how your body uses vitamin D. Vitamin D plays a significant role in immune regulation and implantation, and a variant here can mean supplementation does less than expected.
Not every variant in these genes has been clearly linked with fertility outcomes in large studies, but they can meaningfully change how your methylation pathway behaves and how you respond to nutrients. Each one changes what support is appropriate for you specifically.
If you have had MTHFR identified but nobody has looked at the broader pathway, or checked your homocysteine, or asked about how methylfolate is actually making you feel, that gap is worth addressing.
The goal is not to collect more results. The goal is to understand what is actually happening in your specific body so that support is targeted, appropriate, and genuinely useful to you. Not to you in general. To you specifically.
A Note from My Own Experience
I want to be careful here not to make this about me, because this is about you. But context matters, and I think you deserve to know where I am coming from.
I navigated twelve years of fertility challenges personally, including fifteen losses. I have sat with results that felt like dead ends. I have taken supplements that made things worse before I understood why. I have experienced the particular exhaustion of being told that everything looks normal while knowing, clearly, that something was not right.
Understanding my own methylation profile was part of what eventually shifted things for me. Not as a magic answer. As one piece of a picture that finally started making sense when I stopped looking at each result in isolation and started understanding how they spoke to each other.
That is the work I do with clients. Not handing you a result and a supplement. Sitting with the full picture and building something that actually fits you.
If you have been sitting with an MTHFR result and not enough answers, that is not where the story ends.
Ready to make sense of your results?
If this article has raised more questions than it has answered, that is a good sign. It means you are starting to see that your fertility picture is more complex than a single result, and that the investigation you have had so far may not have gone far enough. That is exactly what I work with.
Start with a Free Discovery Call and learn how a personalised, science-rooted approach can bring clarity and renewed hope.
REFERENCES
Boxmeer, J. C., Brouns, R. M. E., Lindemans, J., Steegers‑Theunissen, R. P. M., & Macklon, N. S. (2009). IVF outcomes are associated with biomarkers of the homocysteine pathway in monofollicular fluid. Human Reproduction, 24(5), 1059–1066. https://doi.org/10.1093/humrep/den493
Carneiro, F. R., Costa, M. A., Fernandes, R. M., & Nogueira, C. A. (2020). Pregnancy outcomes in patients with MTHFR gene polymorphism. Journal of Surgery and Medicine, 4(6), 428–432. https://doi.org/10.28982/josam.768231
de Góes Soligo, A., de Souza, A. M. B., Meirelles, L. M. O., Santiago‑Batista, V. G., Fernandes, K. B. P., Dos Santos, J. E., & Foss, M. C. (2017). Prevalence of the MTHFR C677T mutation in fertile and infertile women. Revista Brasileira de Ginecologia e Obstetrícia, 39(12), 659–662. https://doi.org/10.1055/s‑0037‑1604403
Liew, S. C., & Gupta, E. D. (2015). MTHFR C677T polymorphism: Epidemiology, metabolism and the associated diseases. European Journal of Medical Genetics, 58(1), 1–10. https://doi.org/10.1016/j.ejmg.2014.10.004
Ménézo, Y., Clément, A., Chouteau, J., Déchaud, H., & Servy, E. (2021). MTHFR SNPs and homocysteine in patients referred for investigation of fertility. Journal of Assisted Reproduction and Genetics, 38(9), 2383–2389. https://doi.org/10.1007/s10815‑021‑02186‑6
Royal Australian College of General Practitioners. (2016). MTHFR genetic testing: Controversy and clinical implications. Australian Family Physician, 45(4), 237–240.
Zeng, H., Xiong, Y., Xu, Z., Wu, Y., Wang, C., Liu, Y., Chen, P., & Jiang, H. (2022). MTHFR 677TT is associated with decreased number of embryos and cumulative live birth rate in patients undergoing GnRHa short protocol. BMC Pregnancy and Childbirth, 22, 170. https://doi.org/10.1186/s12884‑022‑04520‑5
The information in this article is for educational purposes only and does not constitute medical advice or replace personalised clinical care. Every person's health picture is unique, and what is appropriate for one individual may not be appropriate for another. If you are navigating fertility challenges, pregnancy loss, or any other health concern, please seek guidance from a qualified health practitioner who can assess your individual circumstances. For individualised assessment and treatment, please consult a qualified health practitioner.
